Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT01604005
Eligibility Criteria:
Inclusion Criteria:
* Either sex, age ≥ 18 years
* Diagnosis of mesothelioma by multi-disciplinary team (MDT). All histological subtypes are eligible for the trial
* ECOG performance status 0-2 (Appendix C)
* Inoperable disease or operable disease in patients unsuitable for surgery as decided by a MDT
* Chest wall intervention with video-assisted thoracoscopy (VATS), open surgical biopsy (mini-thoracotomy), local anaesthetic thoracoscopy or chest drain
* Able to start radiotherapy within 42 days (6 weeks) of the most recent chest wall procedure
* Chest wall intervention scar visible at time of randomisation
* Radiotherapy target volume acceptable by the local radiotherapist
* Patients enrolled on other clinical trials could be considered after discussion with the chief investigators
Exclusion Criteria:
* Patients who underwent a thoracotomy (as large thoracotomy scars may not be adequately covered by this radiotherapy technique)
* Previous radiotherapy to the region of the chest wall intervention site
* Indwelling pleural catheter in-situ at the intervention site
* Patients currently receiving chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01604005
Study Brief:
Protocol Section:
NCT01604005